ClinicalTrials.gg
Not yet recruitingNCT07809061HBO-POSAUpdated Sep 9, 2026

Hypercapnic Burden in Adults With Obesity Undergoing Diagnostic Polysomnography for Suspected Obstructive Sleep Apnea

An interventional study of Sleep Inertia Questionnaire (SIQ) in Obstructive Sleep Apnea, Obesity (BMI>30) and Obesity Hypoventilation Syndrome (OHS), sponsored by Hospices Civils de Lyon. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-09.

Primary conditionObesity Hypoventilation SyndromeRegistry: Sleep Apnea, ObstructiveReclassifiedWhy we changed it
Registry
Sleep Apnea, Obstructive — the first condition term the registry derived for this study.
ClinicalTrials.gg
Obesity Hypoventilation Syndrome
Why
  1. The study's listed conditions name Obesity Hypoventilation Syndrome, a narrower term within Sleep Apnea, Obstructive.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Obesity-related sleep hypoventilation represents a continuum ranging from isolated nocturnal hypoventilation to obesity hypoventilation syndrome. Current diagnostic criteria rely mainly on dichotomous thresholds and may not adequately reflect cumulative nocturnal carbon dioxide exposure.

Hypercapnic burden, defined as the cumulative area under the transcutaneous carbon dioxide (PtcCO₂) curve above a predefined threshold, has recently emerged as a novel physiological marker integrating both the intensity and duration of nocturnal hypercapnia.

This prospective observational cohort study aims to evaluate the association between nocturnal hypercapnic burden and obstructive sleep apnea severity, assessed by the apnea-hypopnea index (AHI), in adults with obesity referred for diagnostic polysomnography.

Secondary objectives include evaluating associations between hypercapnic burden and sleep architecture, respiratory events, oxygenation parameters, daytime symptoms, and patient-reported outcomes. In addition, the study will investigate the relationship between nocturnal hypercapnic burden and sleep inertia, assessed using the Sleep Inertia Questionnaire (SIQ), based on the hypothesis that greater nocturnal carbon dioxide exposure immediately before awakening may contribute to impaired alertness upon awakening.

Hypothesis: Increased nocturnal hypercapnic burden is associated with greater obstructive sleep apnea severity and reflects an additional physiological dimension of obesity-related sleep hypoventilation beyond conventional polysomnographic indices. Furthermore, higher nocturnal hypercapnic burden is hypothesized to be associated with greater sleep inertia.

02

Conditions studied

  • Obstructive Sleep Apnea
  • Obesity (BMI>30)
  • Obesity Hypoventilation Syndrome (OHS)
  • Sleep Hypoventilation

Keywords

  • Hypercapnic burden
  • Transcutaneous carbon dioxide
  • Polysomnography
  • Obesity
  • Sleep apnea
  • Sleep hypoventilation
03

In context

Obesity Hypoventilation Syndrome Reclassified

73 studies on the registry are indexed under Obesity Hypoventilation Syndrome; 10 are open to participants now.

This study's planned enrollment of 150 is above the median of 40 across 42 interventional studies indexed under Obesity Hypoventilation Syndrome.

Browse Obesity Hypoventilation Syndrome studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,866 studies on the registry; 448 are open to participants now.

Compared within Obesity Hypoventilation Syndrome, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Sleep Apnea, Obstructive. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥18 years.
  • (BMI) ≥30 kg/m².
  • Referred to the Sleep Medicine Center for routine diagnostic polysomnography because of suspected obstructive sleep apnea.
  • Affiliated with a French health insurance scheme.
  • Received information about the study and did not object to the use of their data.
  • Able to understand the study information and complete study questionnaires.

Exclusion criteria

Exclusion Criteria:

  • Legal incapacity or inability to provide non-opposition to participation.
  • Previous treatment with continuous positive airway pressure (CPAP) or non-invasive ventilation.
  • Participation in another interventional clinical study that could interfere with the present study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Adults with obesity referred for diagnostic polysomnography

    Adults with obesity (body mass index ≥30 kg/m²) referred to the Sleep Medicine Center for routine diagnostic polysomnography because of suspected obstructive sleep apnea

    Behavioral: Sleep Inertia Questionnaire (SIQ)

Interventions

  • BehavioralSleep Inertia Questionnaire (SIQ)

    The only research-specific procedure is the completion of the Sleep Inertia Questionnaire (SIQ), a self-administered questionnaire requiring approximately 5 minutes to complete and performed once after the diagnostic sleep study.

06

What researchers measure

Primary outcomes

  1. Correlation between nocturnal hypercapnic burden and apnea-hypopnea index

    Correlation between nocturnal hypercapnic burden above 45 mmHg (HB45), defined as the area under the nocturnal transcutaneous carbon dioxide pressure (PtcCO₂) curve above 45 mmHg and normalized per hour of recording (mmHg·min/hour), and the apnea-hypopnea index derived from diagnostic polysomnography (events/hour). The correlation will be assessed using Pearson's or Spearman's correlation coefficient, according to data distribution.

    Time frame: Baseline only (overnight diagnostic polysomnography)

07

Study locations

1 site
  • Croix-Rousse Hospital, Hospices Civils de Lyon
    Lyon, 69004, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07809061
Responsible party
Sponsor
First posted
Sep 9, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Nov 3, 2028 (estimated)
Completion
Nov 3, 2028 (estimated)
Last update
Sep 9, 2026

Study contacts

Pierre TANKERE, Dr
Contact
Pierre.tankere01@chu-lyon.fr
0472071929
Laure PETER DEREX, Pr
Contact
Laure.peter-derex@chu-lyon.fr
0472071929

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion